Interventional Intracranial Aneurysm Devices Are Advancing With Increasing Technological Developments in the Field Of Aneurysm Treatment

Interventional Intracranial Aneurysm Devices
Interventional Intracranial Aneurysm Devices

There are many treatment options for intracranial aneurysms. Some are minimally invasive while others are surgical. The choice of procedure is based on patient preference and operator experience. The treatment options include use of different types of Interventional Intracranial Aneurysm Devices. Some of the common options include aneurysm clipping, endovascular coiling, shunt operation, and lumbar draining catheter. However, the most serious complication is rupture of the aneurysm, which can result in death.

During the past two decades, the treatment of brain aneurysm has changed dramatically. With the emergence of technological advancements, researchers and physicians are now developing innovative surgical procedures to treat brain aneurysms. However, there is still a need for randomized trials to evaluate the effectiveness of these treatments. Several endovascular techniques are used in the treatment of IAs, such as coiling, balloon-assisted coiling, waffle-cone, and wrapping and clipping.

The Interventional Intracranial Aneurysm Devices Market is anticipated to reach US$ 3,670.34 million in 2022 and grow at a CAGR of 7.7% during the forecast period (2022-2030)

The most recent development in the field of aneurysm treatment is the use of the Woven EndoBridge (WEB). This interventional intracranial device prevents blood from entering the aneurysm. Using WEB, surgeons can offer curative treatment for complicated aneurysm cases. The company says that the WEB is about the size of an eraser head and is designed to fill and form the shape of the aneurysm. It can be used to prevent blood from entering the aneurysm and also to deactivate rupturing of the blood vessels.

Several companies have recently launched innovative Interventional Intracranial Aneurysm Devices related technologies and products to treat intracranial aneurysms. These include MicroVention Inc., Stryker, and Terumo Corporation. Moreover, a new generation of biocompatible embolization material is being developed that does not break down in the human body. In fact, the novel material does not decrease over time and does not cause damage to the tissue of the aneurysm. In June 2022, India Medtronic Private Limited introduced CE market fourth-generation flow diverter, Pipeline Vantage having Shield Technology for endovascular treatment of brain aneurysms.

Comments

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

U.S. FDA Has Approved Several Colon and Rectal Cancer Drugs to Treat Colon and Rectal Cancer

Patient-Centered Medical Home; Is Used To Offer High-Standard, Inexpensive Primary Care